These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21626409)

  • 1. Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells.
    Katz JD; Janssen EM
    Cell Mol Life Sci; 2011 Sep; 68(17):2873-83. PubMed ID: 21626409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.
    Katz JD; Ondr JK; Opoka RJ; Garcia Z; Janssen EM
    J Immunol; 2010 Aug; 185(4):1999-2003. PubMed ID: 20644171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIM determines the number of merocytic dendritic cells, a cell type that breaks immune tolerance.
    Audiger C; Lesage S
    Immunol Cell Biol; 2018 Oct; 96(9):1008-1017. PubMed ID: 29754432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.
    Mukhopadhaya A; Hanafusa T; Jarchum I; Chen YG; Iwai Y; Serreze DV; Steinman RM; Tarbell KV; DiLorenzo TP
    Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6374-9. PubMed ID: 18430797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T cells into regulatory T cells and promotes immunotolerance in NOD mice.
    Petzold C; Riewaldt J; Koenig T; Schallenberg S; Kretschmer K
    Rev Diabet Stud; 2010; 7(1):47-61. PubMed ID: 20703438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Idd13 congenic interval defines the number of merocytic dendritic cells, a novel trait associated with autoimmune diabetes susceptibility.
    Pelletier AN; Lesage S
    J Autoimmun; 2013 Jun; 43():70-7. PubMed ID: 23623717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognate CD4+ help elicited by resting dendritic cells does not impair the induction of peripheral tolerance in CD8+ T cells.
    Steptoe RJ; Ritchie JM; Wilson NS; Villadangos JA; Lew AM; Harrison LC
    J Immunol; 2007 Feb; 178(4):2094-103. PubMed ID: 17277113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
    Wiede F; Ziegler A; Zehn D; Tiganis T
    J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.
    Schloss J; Ali R; Babad J; Guerrero-Ros I; Pongsachai J; He LZ; Keler T; DiLorenzo TP
    Immunohorizons; 2019 Jun; 3(6):236-253. PubMed ID: 31356169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.
    Prasad S; Neef T; Xu D; Podojil JR; Getts DR; Shea LD; Miller SD
    J Autoimmun; 2018 May; 89():112-124. PubMed ID: 29258717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC-targeted proinsulin expression inactivates insulin-specific memory CD8
    Reeves PL; Rudraraju R; Liu X; Wong FS; Hamilton-Williams EE; Steptoe RJ
    Immunol Cell Biol; 2017 Oct; 95(9):765-774. PubMed ID: 28611473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice.
    Han J; Zhong J; Wei W; Wang Y; Huang Y; Yang P; Purohit S; Dong Z; Wang MH; She JX; Gong F; Stern DM; Wang CY
    Diabetes; 2008 Aug; 57(8):2118-27. PubMed ID: 18477810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential lipid signaling from CD4
    White TD; Almutairi A; Gai-Tusing Y; Stephenson DJ; Stephenson BD; Chalfant CE; Lei X; Lu B; Hammock BD; DiLorenzo TP; Ramanadham S
    Front Immunol; 2024; 15():1444639. PubMed ID: 39359722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.
    Kiekhaefer CM; Weber B; Huggins M; Gorichanaz C; Nehring JA; DeLuca HF
    Clin Exp Immunol; 2011 Dec; 166(3):325-32. PubMed ID: 22059989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mimovirus encoding ChgA
    Sun H; Han X; Yan X; Xu J; Huang Q; Meng F; Zhang H; Li S
    Cell Immunol; 2017 Oct; 320():56-61. PubMed ID: 28916112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysrulation of T cell peripheral tolerance in type 1 diabetes.
    Tisch R; Wang B
    Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
    Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
    Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.